Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.42 |
| ▸ | GABRP | O00591 | 1/20 | 0.42 |
| ▸ | GABRD | O14764 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31372702 | 1.00 | PRMT1 (0.50) | PRMT1ADRA1AALOX15CYP1A2KMT2A | |
| Hydrochloric Acid SCHEMBL8613561 | 0.98 | PRMT1 (0.48) | PRMT1ADRA1AALOX15CYP1A2KMT2A | |
| SCHEMBL2107302 | 0.93 | PRMT1 (0.59) | PRMT1ADRA1AALOX15CYP1A2KMT2A | |
| Sulfuric Acid SCHEMBL28677592 | 0.92 | ALOX15 (0.56) | PRMT1ADRA1AALOX15CYP1A2KMT2A | |
| SCHEMBL1298943 | 0.91 | PRMT1 (0.63) | PRMT1ADRA1AALOX15CYP1A2KMT2A | |
| SCHEMBL5535128 | 0.91 | PRMT1 (0.63) | PRMT1ADRA1AALOX15CYP1A2KMT2A | |
| SCHEMBL5536342 | 0.91 | PRMT1 (0.63) | PRMT1ADRA1AALOX15CYP1A2KMT2A | |
| SCHEMBL5538332 | 0.91 | PRMT1 (0.63) | PRMT1ADRA1AALOX15CYP1A2KMT2A | |
| SCHEMBL5533492 | 0.91 | PRMT1 (0.63) | PRMT1ADRA1AALOX15CYP1A2KMT2A | |
| SCHEMBL5535532 | 0.91 | PRMT1 (0.63) | PRMT1ADRA1AALOX15CYP1A2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2564 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4297723-B1 | MICRONEEDLE COMPOSITIONS AND METHODS OF DELIVERY USING THE SAME | BRIGHAM & WOMENS HOSPITAL INC (US) | 2026-05-20 | — | — | EP | claimed |
| CN-122005693-A | Application of Jiaweidanzhi Xiaoyao powder or extract thereof in preparation of medicines for treating depression complicated with ulcerative colitis | 河南中医药大学 | 2026-05-12 | — | — | CN | claimed |
| CN-121512985-B | Application of Slc36a1 agonist in preparation of medicines for preventing and/or treating colonitis | 中国医学科学院医药生物技术研究所 | 2026-05-12 | — | — | CN | claimed |
| WO-2026088246-A1 | METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND | ＮＴＴ株式会社 | 2026-04-30 | — | — | WO | claimed |
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-04-09 | — | — | US | claimed |
| US-20260077012-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES | EPITRACKER INC (US) | 2026-03-19 | — | — | US | claimed |
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-01-08 | — | — | US | claimed |
| US-12427179-B2 | Compositions and methods for diagnosis and treatment of neurodegenerative diseases | Epitracker, Inc. (US) | 2025-09-30 | — | — | US | claimed |
| US-20040254338-A1 | Melanin-concentrating hormone antagonists | MERCK SHARP & DOHME CORP. | 2004-12-16 | — | — | US | claimed |
| EP-1416951-A1 | MELANIN-CONCENTRATING HORMONE ANTAGONISTS | Merck & Co., Inc. (US) | 2004-05-12 | — | — | EP | claimed |
| WO-2003013574-A1 | MELANIN-CONCENTRATING HORMONE ANTAGONISTS | MERCK & CO., INC. (US) | 2003-02-20 | — | — | WO | claimed |
| EP-0458949-B1 | STABILIZATION OF K1K2P PRO | BOEHRINGER MANNHEIM GMBH (DE) | 1995-05-03 | — | — | EP | claimed |
| US-5409699-A | Stable, soluble preparations containing sodium citrate and selected compounds | BOEHRINGER MANNHEIM GMBH (DE) | 1995-04-25 | — | — | US | claimed |
| US-5352452-A | Anticoagulants, enzyme activity | BOEHRINGER MANNHEIM GMBH (DE) | 1994-10-04 | — | — | US | claimed |
| US-5352453-A | Acidic ph | BOEHRINGER MANNHEIM GMBH (DE) | 1994-10-04 | — | — | US | claimed |
| EP-0458939-B1 | STABILIZATION OF t-PA pro | BOEHRINGER MANNHEIM GMBH (DE) | 1994-03-23 | — | — | EP | claimed |
| EP-0458930-B1 | STABILIZATION OF GLYCOSYLIZED t-PA | BOEHRINGER MANNHEIM GMBH (DE) | 1993-10-20 | — | — | EP | claimed |
| EP-0458950-B1 | STABILIZATION OF K2P PRO | Roche Diagnostics GmbH (DE) | 1993-09-15 | — | — | EP | claimed |